JAG
Journey Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $818K | Sell |
17,661
-235
| -1% | -$10.9K | 0.06% | 172 |
|
|
2025
Q1 | $1.09M | Buy |
17,896
+75
| +0.4% | +$4.57K | 0.09% | 145 |
|
|
2024
Q4 | $740K | Hold |
17,821
| – | – | 0.09% | 121 |
|
|
2024
Q3 | $740K | Hold |
17,821
| – | – | 0.09% | 121 |
|
|
2024
Q2 | $740K | Sell |
17,821
-9,625
| -35% | -$400K | 0.09% | 121 |
|
|
2024
Q1 | $1.49M | Sell |
27,446
-1,594
| -5% | -$86.4K | 0.18% | 96 |
|
|
2023
Q4 | $1.49M | Sell |
29,040
-29,125
| -50% | -$1.49M | 0.2% | 93 |
|
|
2023
Q3 | $3.38M | Sell |
58,165
-45,038
| -44% | -$2.61M | 0.5% | 60 |
|
|
2023
Q2 | $6.6M | Buy |
103,203
+9,275
| +10% | +$593K | 0.98% | 28 |
|
|
2023
Q1 | $6.51M | Buy |
93,928
+22,973
| +32% | +$1.59M | 1.02% | 24 |
|
|
2022
Q4 | $5.11M | Buy |
70,955
+17,497
| +33% | +$1.26M | 1.27% | 16 |
|
|
2022
Q3 | $3.8M | Buy |
53,458
+7,861
| +17% | +$559K | 0.97% | 21 |
|
|
2022
Q2 | $3.36M | Buy |
45,597
+17,406
| +62% | +$1.28M | 0.77% | 29 |
|
|
2022
Q1 | $2.06M | Buy |
28,191
+7,469
| +36% | +$546K | 0.52% | 52 |
|
|
2021
Q4 | $1.29M | Buy |
20,722
+3,076
| +17% | +$192K | 0.36% | 67 |
|
|
2021
Q3 | $1.04M | Buy |
17,646
+4,019
| +29% | +$238K | 0.34% | 72 |
|
|
2021
Q2 | $911K | Buy |
13,627
+2,155
| +19% | +$144K | 0.29% | 76 |
|
|
2021
Q1 | $724K | Buy |
11,472
+935
| +9% | +$59K | 0.25% | 89 |
|
|
2020
Q4 | $654K | Buy |
+10,537
| New | +$654K | 0.24% | 90 |
|